following a full submission:
testosterone as mucoadhesive buccal tablet 30 mg (Striant SR) is accepted for restricted use within NHSScotland as testosterone replacement therapy in men with primary or secondary hypogonadism.
It offers an alternative to other routes, including transdermal application by patches or gel, for patients who would particularly benefit from this mode of administration where intramuscular treatment is not suitable.
Download detailed advice41KB (PDF)
- Medicine name:
- testosterone mucoadhesive buccal (Striant SR)
- SMC ID:
- as testosterone replacement therapy in men with primary or secondary hypogonadism.
- Pharmaceutical company
- Ardana Bioscience
- BNF chapter
- Endocrine system
- Submission type
- Date advice published
- 08 November 2004